GOGO compared with KROS: revenue, margins and what each company keeps, and the suppliers and customers both name

GOGOGogo Inc.

Mkt capRevenueRevenue

KROSKeros Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

GOGOGogo Inc.

KROSKeros Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GOGO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 7 '26±12.8%▼−0.14%×0.01

May 8 '26±9.4%▼−5.78%×0.62

Mar 2 '26±16.2%▲+12.29%×0.76

Nov 7 '25±10.9%▲+0.39%×0.04

KROS

1 of 3at or beyond implied

Reportimpliedrealized× implied

Nov 6 '26—▼−0.95%—

Aug 4 '26±25.5%▲+1.38%×0.05

= impliedGOGO realized, solidKROS realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

May 14 '26

±32.2%

▼−8.34%

×0.26

Mar 5 '26±12.0%▼−14.96%×1.25

GOGOGogo Inc.

3.88▲+71.30%· post 3.98

Mkt cap$527.0MRevenue$213MQ3 FY26Revenue$910MFY25

KROSKeros Therapeutics, Inc.

9.31▼−1.50%· post 9.31

ClosedNov 6 '26

Mkt cap$183.7MRevenue$40MQ3 FY26Revenue$244MFY25

Compare

ClosedNov 6 '26

GOGOGogo Inc.

KROSKeros Therapeutics, Inc.

3.88▲+71.30%post 3.98

Price

9.31▼−1.50%post 9.31

$527.0M

Mkt cap

$183.7M

Q3 FY26$213M

Revenue

$40MQ3 FY26

FY25$910M

Revenue

$244MFY25

GOGO3.88▲+71.30%vsKROS9.31▼−1.50%ClosedNov 6 '26